F-O (ECS 2000-2009)

FAAH / FATTY ACID AMIDE HYDROLASE (Breaks down Anandamide)
HEMOPRESIN (CB1 Inverse Agonist)
L-a-LYSOPHOSPHATIDYLINOSITOL (GPR55 Agonist)
MAGL / MGL / MONOACYLGLYCEROL LIPASE (Breaks down 2-AG)
NADA / N-ARACHIDONOYLDOPAMINE (CB1 Agonist)
NAGly / N-ARACHIDDONOYL GLYCINE (GPR18 Agonist)
NAPE-PLD (Enzyme Involved in Creating Endocannabinoids)
NARAS / N-ARACHIDONOYL-L-SERINE (Binds very weakly to Cannabinoid CB1 and CB2)
OEA / OLEOYLETHANOLAMIDE (Anandamide Analog, GPR119 Agonist)
OLEA / OLEAMIDE (CB1 Agonist)
OMEGA-3 / CB1 CONNECTION* (Without Omega-3, new CB1 Receptors are Made Imperfectly, See Also NUTRITION-HEMP SEED OIL, CBR-CB1 Receptors)
OMEGA-6 / ENDOCANNABINOID CONNECTION (Some Endocannabinoids are Made From Omega 6, You Need It, But It Is Pro-Inflammatory; Too Much Is Not Good For You. Most Folks Get Too Much)


FAAH / FATTY ACID AMIDE HYDROLASE
Differences in the pharmacological properties of rat and chicken brain fatty acid amidohydrolase (full–2000) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572338/
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase (full–2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC55427/?tool=pubmed
Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma
and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide (full–2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572744/
Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells (full–2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1222054/pdf/11485574.pdf/?tool=pmcentrez
Effects of pH on the inhibition of fatty acid amidohydrolase by ibuprofen (full–2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572815/
Fatty acid amide hydrolase inhibition by neurotoxic organophosphorus pesticides (abst–2001) http://www.ncbi.nlm.nih.gov/pubmed/11350214
Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer (full–2002) http://molehr.oxfordjournals.org/content/8/2/188.full
Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide
interacting with both the cannabinoid and vanilloid signalling systems (abst–2002)  http://www.ncbi.nlm.nih.gov/pubmed/12570018
Endocannabinoids and related fatty acid derivatives in pain modulation (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12505698
Regulation of anandamide tissue levels by N-arachidonylglycine (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12234618
Endocannabinoids in the central nervous system-an overview (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12052038
Anandamide metabolism by fatty acid amide hydrolase in intact C6 glioma cells. Increased sensitivity to inhibition by ibuprofen and flurbiprofen upon reduction of extrabut not intracellular pH (abst–2003) http://www.ncbi.nlm.nih.gov/pubmed/12644895
A structure-activity relationship study on N-arachidonoyl-amino acids as possible endogenous inhibitors of fatty acid amide hydrolase (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/14715265
The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity (full–2005) http://www.jlr.org/content/46/2/342.long
Dual modulation of endocannabinoid transport and fatty acid amide hydrolase protects against excitotoxicity (full–2005) http://www.jneurosci.org/content/25/34/7813.long
Fatty acid amide hydrolase deficiency limits early pregnancy events (full–2005) http://www.jci.org/articles/view/28621
Fatty acid amidohydrolase in human neocortex-activity in epileptic and non-epileptic brain tissue and inhibition by putative endocannabinoids (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15923084
Cisplatin increases brain 2-arachidonoylglycerol (2-AG) and concomitantly reduces intestinal 2-AG and anandamide levels in the least shrew (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15921709
Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models (full–2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1751298/?tool=pmcentrez
A second fatty acid amide hydrolase with variable distribution among placental mammals (full–2006) http://www.jbc.org/content/281/48/36569.long
Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16480822
Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16949718
The Endogenous Cannabinoid Anandamide Produces δ-9-Tetrahydrocannabinol-Like Discriminative and Neurochemical Effects That Are Enhanced by Inhibition of Fatty Acid Amide Hydrolase but Not by Inhibition of Anandamide Transport (full–2007) http://jpet.aspetjournals.org/content/321/1/370.full
The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3′-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice (full–2007) http://jpet.aspetjournals.org/content/322/1/236.long
Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225473/?tool=pubmed
Oleamide: a fatty acid amide signaling molecule in the cardiovascular system? (full–2007) http://onlinelibrary.wiley.com/doi/10.1111/j.1527-3466.2007.00004.x/full
Fatty acid amide hydrolase: from characterization to therapeutics (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17712824
Attenuation of allergic contact dermatitis through the endocannabinoid system (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17556587
Organophosphate-Sensitive Lipases Modulate Brain Lysophospholipids, Ether Lipids and Endocannabinoids (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582404/
Activation of the endocannabinoid system by organophosphorus nerve agents (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597283/
Genetic Loss of Faah Compromises Male Fertility in Mice (full-2008) http://www.biolreprod.org/content/80/2/235.long
Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB1 receptors and fatty acid amide hydrolase (full–2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2008.01114.x/full
The FAAH inhibitor URB-597 ameliorates cannabinoid withdrawal in mice (abst–2008) http://www.fasebj.org/cgi/content/meeting_abstract/22/1_MeetingAbstracts/711.6?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=720&resourcetype=HWCIT
Presence of functional cannabinoid receptors in human endocrine pancreas (abst–2008) http://www.frontiersin.org/publications/18092149
Presence of functional cannabinoid receptors in human endocrine pancreas (full–2008) http://tinyurl.com/hc2d4c7
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18028339
Cat odour-induced anxiety-a study of the involvement of the endocannabinoid system (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/17882402
Genetic deletion of Fatty Acid Amide Hydrolase results in improved long-term outcome in chronic autoimmune encephalitis (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18501510
Overview of the chemical families of fatty acid amide hydrolase and monoacylglycerol lipase inhibitors (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18289091
Understanding the Effects of Endogenous Cannabinoids (news–2008) http://arstechnica.com/science/2008/11/understanding-the-effects-of-endogenous-cannabinoids/
Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects (full–2009) http://onlinelibrary.wiley.com/doi/10.1111/j.1601-183X.2009.00518.x/full
ALTERED ANANDAMIDE DEGRADATION IN ATTENTIONDEFICIT/HYPERACTIVITY DISORDER (full–2009) http://www.neurology.org/content/72/17/1526.long
Mechanisms involved in oleamide-induced vasorelaxation in rat mesenteric resistance arteries (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664517/
Role of endocannabinoid signaling in anxiety and depression (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808114/
Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo (full–2009) http://www.pnas.org/content/106/48/20270.long
Endocannabinoid modulation of scratching response in an acute allergenic model: a new prospective neural therapeutic target for pruritus (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2670585/?tool=pubmed
Endocannabinoids and reproductive biology (letter-2009) http://humrep.oxfordjournals.org/content/24/7/1771.full.pdf+html
Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/17397826
Endocannabinoids: friends and foes of reproduction (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19602425
Endocannabinoids, sperm biology and human fertility (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19559363
Effects of central endocannabinoid system on visceral hyposensitivity induced by rapid eye movement sleep deprivation: experiment with rats (abst–2009) http://science.naturalnews.com/2009/1199881_Effects_of_central_endocannabinoid_system_on_visceral_hyposensitivity_induced_by.html
Modulation of the endocannabinoid-degrading enzyme fatty acid amide hydrolase by follicle-stimulating hormone (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19647115
Skeletal anabolic activity of cannabinoid receptor agonists (abst-2009) http://www.thebonejournal.com/article/S8756-3282%2809%2900121-5/abstract
Skeletal anabolic activity of cannabinoid receptor agonists (abst-2009) http://www.thebonejournal.com/article/S8756-3282%2809%2900121-5/abstract


HEMOPRESIN
Hemopressin is an inverse agonist of CB1 cannabinoid receptors (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2154475/
Novel endogenous peptide agonists of cannabinoid receptors (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2735371/


L-a-LYSOPHOSPHATIDYLINOSITOL
The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation (full–2009) http://www.fasebj.org/content/23/1/183.long


MAGL / MGL / MONOACYLGLYCEROL LIPASE
Monoacylglycerol lipase inhibition by organophosphorus compounds leads to elevation of brain 2-arachidonoylglycerol and the associated hypomotility in mice (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16310817
Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16949718
A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2- Arachidonoylglycerol (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2692834/
Organophosphate-Sensitive Lipases Modulate Brain Lysophospholipids, Ether Lipids and Endocannabinoids (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582404/
Activation of the endocannabinoid system by organophosphorus nerve agents (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597283/
Endocannabinoids in the retina: from marijuana to neuroprotection (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584875/
Presence of functional cannabinoid receptors in human endocrine pancreas (abst–2008) http://www.frontiersin.org/publications/18092149
Endogenous cannabinoids: structure and metabolism (full-2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2008.01676.x/full
Overview of the chemical families of fatty acid amide hydrolase and monoacylglycerol lipase inhibitors (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18289091
Understanding the Effects of Endogenous Cannabinoids (news–2008) http://arstechnica.com/science/2008/11/understanding-the-effects-of-endogenous-cannabinoids/
Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances retrograde endocannabinoid signaling (full–2009) http://jpet.aspetjournals.org/content/331/2/591.long
Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarizationinduced suppression of excitation in autaptic hippocampal neurons (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784730/
The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757311/
Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo (full–2009) http://www.pnas.org/content/106/48/20270.long
Effects of central endocannabinoid system on visceral hyposensitivity induced by rapid eye movement sleep deprivation: experiment with rats (abst–2009) http://science.naturalnews.com/2009/1199881_Effects_of_central_endocannabinoid_system_on_visceral_hyposensitivity_induced_by.html


NADA / N-ARACHIDONOYLDOPAMINE
Endocannabinoids and related fatty acid derivatives in pain modulation (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12505698
Characterisation of the vasorelaxant properties of the novel endocannabinoid Narachidonoyl- dopamine (NADA) (full–2004) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574254/
TRPV1 and CB(1) receptor-mediated effects of the endovanilloid/endocannabinoid Narachidonoyl- dopamine on primary afferent fibre and spinal cord neuronal responses in the rat (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/15245490
Mechanisms of HIV-1 inhibition by the lipid mediator N-arachidonoyldopamine (full–2005) http://www.jimmunol.org/content/175/6/3990.long
Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and Narachidonoyldopamine (NADA) in the rat isolated aorta (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15659311
Targeted lipidomics: fatty acid amides and pain modulation (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/16099389
Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17459108
Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2 (full–2008) http://molpharm.aspetjournals.org/content/73/2/441.long
N-arachidonoyl dopamine is a possible factor of the rate of tentacle formation in freshwater hydra (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18409382
The role of the CB1 receptor in the regulation of sleep (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18514375
The biosynthesis of N-arachidonoyl dopamine (NADA), a putative endocannabinoid and endovanilloid, via conjugation of arachidonic acid with dopamine (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757501/
Opposite effects of anandamide and n-arachidonoyl dopamine in the regulation of prostaglandin E2 and 8-iso-PGF2α formation in primary glial cells (full–2009) http://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2009.05966.x/full
Enhancement of the hypotensive effects of intrathecally injected endocannabinoids by the entourage compound palmitoylethanolamide (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19289116


NAGly / N-ARACHIDDONOYL GLYCINE
Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain (full–2001) http://www.jbc.org/content/276/46/42639.long
Regulation of anandamide tissue levels by N-arachidonylglycine (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12234618
A structure-activity relationship study on N-arachidonoyl-amino acids as possible endogenous inhibitors of fatty acid amide hydrolase (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/14715265
N-Arachidonyl-glycine inhibits the glycine transporter, GLYT2a (full–2006) http://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2006.04107.x/full
Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein coupled receptor GPR18 (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16844083/
Actions of N-arachidonyl-glycine in a rat inflammatory pain model (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2042976/
Actions of N-arachidonyl-glycine in a rat neuropathic pain model (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/17588618
The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689249/?tool=pubmed
N-arachidonoyl glycine (article–2009) http://www.lipidmaps.org/update/2009/090801/full/lipidmaps.2009.19.html?s=cannabinoid


NAPE-PLD
Age dependent accumulation of N-acyl-ethanolamine phospholipids in ischemic rat brain. A (31)P NMR and enzyme activity study (full–2000) http://www.jlr.org/content/41/6/985.long
Fatty acid amide hydrolase deficiency limits early pregnancy events (full–2005) http://www.jci.org/articles/view/28621
Isolation and analysis of candidate myeloid tumor suppressor genes from a commonly deleted segment of 7q22 (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15820312
A biosynthetic pathway for anandamide (full-2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557387/
Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16949718
Evolutionary Origins of the Endocannabinoid System (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16434153
Regulation of brain anandamide by acute administration of ethanol (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1868843/
Endocannabinoid Dysregulation in the Pancreas and Adipose Tissue of Mice Fed With a High-fat Diet (full-2008) http://onlinelibrary.wiley.com/doi/10.1038/oby.2007.106/pdf
Endogenous cannabinoids: structure and metabolism (full-2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2008.01676.x/full
The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19059369
Skeletal anabolic activity of cannabinoid receptor agonists (abst-2009) http://www.thebonejournal.com/article/S8756-3282%2809%2900121-5/abstract


NARAS / N-ARACHIDONOYL-L-SERINE
N-arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory properties (full–2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1413724/
N-arachidonoyl L-serine, a putative endocannabinoid, alters the activation of N-type Ca2+ channels in sympathetic neurons (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2652135/
Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2 (full–2008) http://molpharm.aspetjournals.org/content/73/2/441.long


OEA / OLEOYLETHANOLAMIDE
Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders (abst–2000) http://www.ncbi.nlm.nih.gov/pubmed/11106791
Anandamide degradation and N-acylethanolamines level in wild-type and CB1 cannabinoid receptor knockout mice of different ages (full–2001) http://onlinelibrary.wiley.com/doi/10.1046/j.1471-4159.2001.00413.x/full
‘Entourage’ effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism (full–2002) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573364/
N-Acylethanolamines in human reproductive fluids (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12505702
p53-Independent ceramide formation in human glioma cells during gamma-radiation induced apoptosis (full-2004) http://www.nature.com/cdd/journal/v11/n8/full/4401428a.html
The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity (full–2005) http://www.jlr.org/content/46/2/342.long
Synergistic antinociceptive effects of anandamide, an endocannabinoid, and nonsteroidal anti-inflammatory drugs in peripheral tissue: a role for endogenous fatty-acid ethanolamides? (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/17027744
‘Entourage’ effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597234/?tool=pubmed
Gastrointestinal Regulation of Food Intake: General Aspects and Focus on Anandamide and Oleoylethanolamide (full–2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2008.01686.x/full
Endocannabinoids and nutrition (full–2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2008.01687.x/full
Targeted enhancement of oleoylethanolamide production in proximal small intestine induces across-meal satiety in rats (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2494809/?tool=pubmed
The lipid messenger OEA links dietary fat intake to satiety (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2572640/?tool=pubmed
Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528830/?tool=pubmed
An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694060/
Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18535023
Biological functions and metabolism of oleoylethanolamide (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18704536
The role of the CB1 receptor in the regulation of sleep (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18514375
Inhibitory effect of the anorexic compound oleoylethanolamide on gastric emptying in control and overweight mice (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18278475
Fat-induced satiety factor oleoylethanolamide enhances memory consolidation (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683095/?tool=pubmed
GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671052/?tool=pubmed
Sleep deprivation increases oleoylethanolamide in human cerebrospinal fluid (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757605/?tool=pubmed
Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716432/?tool=pubmed
Receptors for acylethanolamides-GPR55 and GPR119 (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751869/?tool=pubmed
N-oleoyl ethanolamine (OEA) (article–2009) http://www.lipidmaps.org/update/2009/090527/full/lipidmaps.2009.9.html?s=cannabinoid
Remembering dinner: OEAsy does it (article–2009) http://www.lipidmaps.org/update/2009/090527/full/lipidmaps.2009.6.html?s=cannabinoid
Oleoylethanolamide exerts partial and dose-dependent neuroprotection of substantia nigra dopamine neurons (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19070629
Plasma endocannabinoid levels in multiple sclerosis (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19695579
N-acylethanolamines, anandamide and food intake (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19413995
Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19095868


OLEA / OLEAMIDE
Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors (full–2004) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574194/
Vasorelaxant effects of oleamide in rat small mesenteric artery indicate action at a novel cannabinoid receptor (full–2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1616976/
Enhanced radiosensitization of p53 mutant cells by oleamide (abst-2006) http://www.ncbi.nlm.nih.gov/pubmed/16580498
Oleamide: a fatty acid amide signaling molecule in the cardiovascular system? (full–2007) http://onlinelibrary.wiley.com/doi/10.1111/j.1527-3466.2007.00004.x/full
Fatty acid amide hydrolase: from characterization to therapeutics (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17712824
Anxiolytic-like effects of oleamide in group-housed and socially isolated mice (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17521793
Neuropharmacological effects of oleamide in male and female mice (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17588682
Overview of the chemical families of fatty acid amide hydrolase and monoacylglycerol lipase inhibitors (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18289091
Effect of oleamide on pentylenetetrazole-induced seizures in rats (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/19023975
Mechanisms involved in oleamide-induced vasorelaxation in rat mesenteric resistance arteries (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664517/


OMEGA-3 / CB1 CONNECTION
Nutrition for Moms-to-be! (article–undated) http://manitobaharvest.com/articles_studies/3812/Hemp-Packs-in-Powerful-Source-of-Preconception-Nutrition.html
Omega-3 and Omega-6 Essential fatty Acids (EFA) (infomercial/ad–undated) http://www.advance-health.com/efa.html
Effect of maternal under-nutrition on pup body weight and hypothalamic endocannabinoid levels (abst–2003) http://www.ncbi.nlm.nih.gov/pubmed/12678501
Oily fish makes ‘babies brainier’ (news-2006) (hemp seed – at the end) http://news.bbc.co.uk/2/hi/health/4631006.stm
Effect of dietary hempseed intake on cardiac ischemia-reperfusion injury (full–2007) http://ajpregu.physiology.org/content/292/3/R1198.long
n-3 Fatty acids and the endocannabinoid system (letter–2007) http://ajcn.nutrition.org/content/85/3/919.1.long
Endocannabinoids and nutrition (full–2008)
http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2008.01687.x/full
Endocannabinoids and nutrition (full–2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2008.01687.x/full
Review of Nutritional Attributes of GOOD OIL (Cold Pressed Hemp Seed Oil) (full–2008) http://www.goodwebsite.co.uk/kingsreport.pdf
Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18316044
Deficit in prepulse inhibition in mice caused by dietary n-3 fatty acid deficiency (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2852869/
Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats (full–2009) http://jn.nutrition.org/content/139/8/1495.long
Benefit of Hemp Oil (news–2009) http://www.livestrong.com/article/31903-hemp-seed-oil-benefits/


OMEGA-6 / ENDOCANNABINOID CONNECTION
Endocannabinoids in the retina: from marijuana to neuroprotection (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584875/